BASE PAIR BIOTECHNOLOGIES INC
Pearland, TX · Founded 2012 · CIK 0001710728 · Medtech · Private
Compensated interferometric reader (CIR) with near-surface assay methodology for rapid detection of opioids, drugs, and environmental contaminants at pg/mL-ng/mL sensitivity
basepair.bio →- Grants
- $6.9M
- 18 awards
- Sector median: 1
- Raised
- $1.9M
- 1 Form D · Jul 2017
- 110 months since last filing
- Contracts
- $2.1M
- 17 awards · Health and Human S, Agriculture, Defense
- #218 of 4531 in medtech
- Patents
- 25
- 7 granted · 18 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Health and Human Services · Igf::ot::igf Tenofovir/apatamers | $13,246 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf | $199,565 | |
| Federal contract | Department of Agriculture · Igf::ot::igf For Other Functions // Attn: Lara HICOK//13LJH4337//SCREENING Dna Aptamer Pool/proprietary Materials Per Mta. | $10,600 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf 2014 SBIR Phase I, Topic 19 | $150,000 | |
| Federal contract | Department of Agriculture · Igf::ot::igf For Other Functions// Custom Synthesis Of A 96-ARRAY Containg 48-APTAMER Clones, Biotin Labelled | $6,140 | |
| Federal contract | Department of Agriculture · Igf::ot::igf For Other Functions // Attn: Lara HICOK//14LJH1622//APTAMER Screening By Base Pairs Biotech: Quote BPB0359 | $27,065 | |
| Federal contract | Department of Defense · Dna Aptamer | $24,100 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf - Services For Development Of Non-modified (natural) Clonal Dna Aptamers To Nontoxic BL1 Ricin B-chain Target | $52,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Rna Aptamers Against Taneia Solium Worm | $39,800 | |
| Federal grant | Department of Health and Human Services · Phase I · Aptamers and BSI for Sub-Microliter Analysis of Pharmaceuticals in Neonatal Urine | $218,783 | |
| Federal grant | Department of Health and Human Services · Phase I · Aptamers and BSI for Sub-Microliter Analysis of Pharmaceuticals in Neonatal Urine | $218,783 | |
| Federal contract | Department of Health and Human Services · Igf::cl::igf - Project On Validation Of Aptamer Binding To Ricin B-chain And Ricin Holotoxin In The Presence Of Complex Food Materials | $39,900 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Dna Affinity Probes | $149,000 | |
| Private capital raised | Form D · SEC | $1,861,710 | |
| Federal grant | Department of Health and Human Services · Phase I · SBIR, PA16-302, Point-of-care aptamer-based surface enhanced Raman scattering (aptamer-SERS) detection of malaria metabolites in urine and saliva | $150,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Aptamer Development | $125,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Topic 372 Development And Validation Of Non-mouse Reagents To Enable Preclinical Development Of Novel Therapeutics- Moonshot | $300,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf- Paratyroid Hormone Aptamer | $38,500 | |
| Federal grant | Department of Health and Human Services · Phase II · Neonatal Opioid Screening Using Aptamers and Compensated Interferometry | $215,306 | |
| Federal grant | Department of Agriculture · Optimization Of A Prototype Lateral Flow Test For Dicamba | $100,000 | |
| Federal contract | Department of Health and Human Services · 068, Development Of Aptamer Affinity Reagents To Immune Targets In Non-human Disease Models | $600,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Neonatal Opioid Screening Using Aptamers and Compensated Interferometry | $99,997 | |
| Federal grant | Department of Health and Human Services · Phase I · Rapid, Quantitative Point-of-Care Measurement of Tuberculosis Treatment Adherence | $221,014 | |
| Federal grant | Department of Health and Human Services · Phase II · Neonatal Opioid Screening Using Aptamers and Compensated Interferometry | $582,503 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Neonatal Opioid Screening Using Aptamers and Compensated Interferometry | $1,142,386 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Rapid, Quantitative Point-of-Care Measurement of Tuberculosis Treatment Adherence | $221,014 | |
| Federal grant | Department of Agriculture · Summary Of Phase II Effort:by The End Of The Phase II Effort, We Will Have Established A Novel Platform For Routine Field Testing Of Arbitrary Water Samples For Dicamba. The Test Will Have A Sensitivity Relevant To Monitoring Spray Equipment For Residual Herbicide Which Could Greatly Injure Sensitive Non-engineered Crops. We Will Also Develop Novel Aptamers To At Least Three Other Herbicides Including 2,4-D, Glyphosate (roundup), And Glufosinate. The Development Of These Tests Will Follow What W | $600,000 | |
| Federal contract | Department of Health and Human Services · Base Pair Custom Aptamers R&d Services | $28,875 | |
| Federal grant | Department of Health and Human Services · Phase II · Neonatal Opioid Screening Using Aptamers and Compensated Interferometry | $559,883 | |
| Federal grant | Department of Health and Human Services · Phase I · Aptamer engineering of lentiviral vectors for cardiac gene therapies | $289,665 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection | $266,072 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection | $266,072 | |
| Federal grant | Department of Health and Human Services · Phase II · Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection | $751,525 | |
| Federal contract | Department of Health and Human Services · Aptasensors For Measuring Long Term Adherence To Tenofovir-based And Long Acting Hiv Treatment Regimens | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Bench-top Reader and Aptamer-based Assay for Rapid, High-sensitivity Drug/Opiate Detection | $746,175 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 215 | X-Therma Inc. | $2.2M | $35M |
| 216 | FARUS, LLC | $2.1M | — |
| 217 | BIOMEDOMICS, INC. | $2.1M | $1.5M |
| 218 | BASE PAIR BIOTECHNOLOGIES INC | $2.1M | $1.9M |
| 219 | Prentke Romich Company | $2.1M | — |
| 220 | ATTUNE NEUROSCIENCES, INC. | $2.0M | — |
| 221 | NEURONEXUS TECHNOLOGIES | $2.0M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ashok GowdaDirector · Executive Officer
- Michele GowdaDirector
- George JacksonDirector · Executive Officer
- Derek RustonDirector
- Vicki SingerDirector · Executive Officer
Patents
- Functional Ligands To Target Vitamin Cgranted
- Methods And Materials For Discovery Of Functional Ligands To Molecular Complexesgranted
- Methods And Materials For Multiplexed Collections Of Functional Ligandsgranted
- Functional Ligandsapplication
- Functional Ligands To Opioids And Opioid Derivativesgranted
- Functional Ligands To Colistingranted
- Functional Ligands To SARS-COV-2 Spike Proteinapplication
- Functional Ligands To Drug Compoundsgranted
- Functional Ligands To Dicambaapplication
- Functional Ligands To LL37granted
- Functional Ligands To Opioids And Opioid Metabolitesapplication
- Functional Ligands To Dicambaapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.